Stratistics Market Research Consulting

Active Pharmaceutical Ingredients Market Report 2017, Trends, Analysis, Share, Estimates and Forecasts to 2022.

Press Release   •   May 31, 2017 23:55 EDT

Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.

Generic/Non- Branded segment witnessed the largest market share during the forecast period due to rising healthcare costs, government prominence on generics for dropping healthcare costs, and decreasing pipelines of global pharmaceutical products. Asia Pacific is expected to be highest market share during the forecast period due to low operation costs and high investments in medical research. Moreover, the high cost of skilled labour and energy are the most significant factors that enforced European market to move its base to developing countries, such as India and China.

Some of the key players in global Active Pharmaceutical Ingredients market include Bioniche Animal Health (Canada), Boehringer Ingelheim (Germany), Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Bayer Healthcare (Germany), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Ceva Animal Health, Inc., Dr. Reddy’s Laboratories Ltd., Novartis International AG, Ranbaxy Laboratories, Virbac, Zoetis (U.S.), Pfizer, Inc, Aurobindo Pharma Ltd., and Heska Co. (U.S.).

For More, Please Visit: http://www.strategymrc.com/report/active-pharmaceutical-ingredients-market-2016

Types of API Covered:
• Synthetic chemical API
o Branded/ Innovative
o Generic/Non- Branded
• Biological API
o Biotech
o Biosimilar
• High potency active pharmaceutical ingredients(HPAPI)

Manufacturing Types Covered:
• Captive (or in-house) manufacturing
• Contract manufacturing

Therapeutic Applications Covered:
• Anti-Infectives
• Cardiovascular and hematopoietic system
• CNS and Neurological Disorders
• Diabetes
• Endocrinology
• Gastrointestinal disorder
• Hormonal-related disorder
• Metabolic disorder
• Musculoskeletal disorder
• Nephrology
• Oncology
• Ophthalmology
• Orthopedic Disorders
• Pulmonology

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

For More, Please Visit: http://www.strategymrc.com/report/active-pharmaceutical-ingredients-market-2016

We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.